Some one showed me some charting that showed ISIS is headed toward the low $30 sooner then later. Basically by the end of the year.
I can't disagree that the stock is undervalued, but until there is steady income, more then milestone payments, ISIS will remain unstable. If it where to jump to $31 in the next month or two I'd mostly likely find myself selling at least 1/3 of my position to cash out my initial investment.
If it goes up, I made money, if it goes down, I made money and can repurchase the shares at a lower price if I want. It's just a HUGE percentage gain in a short time. People seem to think all of these drugs will come to market. there is no guarantee of that. ISIS just has a Very good pipeline with a fantastic chance to get several of those to market.
Milestone payments keep the research going and partnerships mitigate risk.